Macquarie Group’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Macquarie Group’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-800,000	Closed	-$19.3M	–	1642
2014 Q2	$19.3M	Buy	800,000 +66,400	+9%	+$692K	0.04%	366
2014 Q1	$4.42M	Hold	733,600	–	–	0.01%	704
2013 Q4	$4.39M	Buy	733,600 +483,600	+193%	+$2.24M	0.01%	673
2013 Q3	$1.3M	Buy	250,000 +25,000	+11%	+$110K	﹤0.01%	1091
2013 Q2	$812K	Buy	+225,000	New	+$920K	﹤0.01%	1191

Macquarie Group's IDIX Position: Q3 2014 in Review

Macquarie Group sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 800,000 shares — an estimated $19.3M sold.

Macquarie Group first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $19.3M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Macquarie Group reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Macquarie Group sold 800,000 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $19.3M.
Macquarie Group first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
Macquarie Group's IDENIX PHARMACEUTICALS INC position peaked at $19.3M in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Macquarie Group's 13F filing for Q3 2014, filed 14 Nov 2014.